The current state and the development prospects of the ukrainian market of antihistamines
Keywords:allergic diseases, pharmaceutical market, antihistamines
Nowadays allergy has become a global problem for all humanity. According to the WHO about 30-40 % of the world’s population suffers from allergic diseases. Environment pollution, as well as everyday use of a large number of synthetic substances, contribute to the rapid increase in incidence of allergic reactions. The therapy of these diseases is based mainly on the antihistamine drugs (AHD), which makes it reasonable to study the Ukrainian market of AHD and to identify its promising directions of development.
Aim. To study the assortment of antihistamine drugs registered in Ukraine.
Materials and methods. The analysis was based on the official sources of information and materials of the previous marketing research using the methods of systematic, graphical and comparative analysis with the subsequent obtaining of explanations and conclusions.
Results. During the analysis of the domestic pharmaceutical market regarding the assortment of antihistamines it has been found that 128 drugs are used in Ukraine for the treatment of allergic diseases. The study of distribution by dosage forms has revealed the prevalence of solid dosage forms – tablets and dragee – their percentage is 71 %. The analysis of AHD by the manufacturing countries has shown the import dependence of the Ukrainian market: the foreign manufacturers represent 61 % of the drugs. Moreover, in recent years there is a downward trend of the share of domestic manufacturers (50 % – in 2014; 39 % – in 2019). India is the largest importer of antihistamines at the market (17.2 %); the total market share of the European Union countries is 39 %. The analysis of the current state of the pharmaceutical market has determined a change in the distribution of AHD by INN in favor of the new-generation drugs. The study has revealed the absence of anti-allergic herbal medicines in Ukraine; it substantiates the development of new drugs for the phytotherapy of allergic diseases.Conclusions. The absence of plant-based anti-allergic drugs at pharmaceutical market of Ukraine has been found. Taking into account an increasing popularity of herbal medicines and growing demand for drugs with a good safety profile we have concluded that the development of a new plant-based drug for the allergy treatment is a topical direction for further studies.
Pawankar, R., Canonica, G. W., Holgate, S. T., Lockey, R. F. (Eds.). (2012). White book of World Allergy Organization. World Allergy Organization, 3 (52), 33-41.
Phakadze, I, Shavlakadze, N., Lezhava, D., Silagadze, A., Chkhikvadze, L. (2019). Allergology and Immunology, 20 (1), 14-16.
Hatskaia, D. O., Koritskaia, I. V. (2015). Asthma and Allergy, 1, 17-22.
Pukhlik, B. M. (2011). Zaporozhskii meditsinskii zhurnal, 13 (2), 108-110.
Schuler, Iv. C. F., Montejo, M. J. (2019). Pediatr Clin N Am, 66, 981–993.
Apel, K. (2019) npj Primary Care Respiratory Medicine, 29:29, 1-8. doi: 10.1038/s41533-019-0141-y.
Cezmi, A. Akdis, Ioana, Agache. (2014). EAACI, 388.
Kareva, E. N. (2016). RMJ. Medical Review, 12, 811-816.
Luss, L. V. (2010). Asthma and Allergy, 1-2, 70-76.
Chernykh, V. P., Zupanets, I. A., Kupnovytska, I. G. (Eds.). (2013). Klinichna farmatsiia. Kharkiv: NFaU: Zolotі Storinki, 912.
Luss, L. V., Il’ina, N.I. (2017). V pomoshch prakticheskomu vrachu, 184.
Iakovlieva, L. V., Berdnik, O. G., Gurtiakova, A. O. (2018). Pharmaceutical journal, 1-2, 12-21.
Iakovlieva, L. V., Sizenko, M. O. (2014). Pharmaceutical Journal, 277.
Iakovlieva, L. V., Perederii, A. V. (2016). Management, economy and quality assurance in pharmacy, 87-94.
Lukianchuk, E. (2013). Weekly Pharmacy, 4 (875). Available at: http://www.apteka.ua/article/202653 (Date of access: 03.03.20200).
State Statistics Service of Ukraine. Available at: http://ukrstat.gov.ua/ (Date of access: 03.03.20200).
Iakovlieva, L. V., Kyrichenko, N. O., Lukashevych, P. Y. (2016). Endocrinology, 21 (2), 119-124. Available at: URL: http://nbuv.gov.ua/UJRN/enkrl_2016_21_2_6 (Date of access: 03.03.20200).
State register of drugs of Ukraine. Available at: http://www.drlz.com.ua/ (Date of access: 03.03.20200).
Compendium on-line. Available at: https://compendium.com.ua (Date of access: 03.03.20200).
Shostak, T. A., Kaliniuk, T. G., Gudz, N. I. (2014). Phytotherapy. The Chronicle,4, 77-82.
Shostak, L. G., Palchik, K. O. (2018). Young scientist, 3 (55), 425-429.
Thangam, E. B., Jemima, E. A., Singh, H., Baig, M. S., Khan, M., Clinton, B. Mathias, Martin, K. Church, Saluja, R. (2018). The hunt for New Therapeutic Targets. Front. Immunol., 9: 1873, 1-9.
Comprehensive medical video library. Available at: http://www.Osmosis.org (Date of access: 03.03.20200).
Gilmana, G., Khardman, Dzh., Limberd, L. (Eds.). (2006). Klinicheskaia farmakologiia po Gudmanu i Gilmanu.Moscow: Praktika, 336.
Zaikov, S.V. (2013). Allergology. Poglyad fakhіvtsya, 43.
Copyright (c) 2020 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).